Quince Therapeutics, Inc. (QNCX)
0.1257
-0.01
(-9.24%)
USD |
NASDAQ |
Feb 27, 16:00
0.1203
-0.01
(-4.30%)
After-Hours: 20:00
Quince Therapeutics Research and Development Expense (TTM) : 28.61M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Recursion Pharmaceuticals, Inc. | 425.27M |
| Masimo Corp. | 126.40M |
| Ocular Therapeutix, Inc. | 197.10M |
| Gossamer Bio, Inc. | 161.14M |
| Ernexa Therapeutics, Inc. | 4.638M |